APEA (Latest 2023 / 2024) Pharm Mens Health Exam
(ACTUAL TEST ) Questions and Answers (Solved)
• Alpha-adrenergic antagonists for the treatment of benign prostatic hyper- plasia
(BPH)::
block alpha adrenergic receptors • Ciprofloxacin, used for the treatment of bacterial prostatitis, is a potent CYP1A2 inhibitor and is absolutely contraindicated with other CYP1A2 in- hibitors. An example of another CYP1A2 inhibitor is:: tizanidine (Zanaflex) • A 65-year-old man who is receiving finasteride (Proscar) for benign prosta- tic hyperplasia (BPH) is exhibiting progressive symptoms. To reduce these symptoms, prescribe:: doxazosin (Cardura) • A 57-year-old man has chronic prostatitis with a causative organism that is resistant to fluoroquinolones. The patient has an allergy to sulfa drugs. The next best treatment option is:: doxycycline (Doryx) 1 / 2
• To avoid esophageal irritation, patients taking doxycycline (Doryx) for the treatment of epididymitis should be advised to:: avoid taking just before bed • PDE-5 inhibitors, such as vardenafil (Levitra), are indicated in the treatment of:: erectile dysfunction • Finasteride (Proscar) is an:: 5-alpha reductase inhibitor • Which of the following is NOT a fluoroquinolone used to treat prostatitis?-
: Keflex
• A 65-year-old man with benign prostatic hyperplasia (BPH) is treated with tamsulosin (Flomax). Potential side effects are:: orthostatic hypotension and dizziness • Patients receiving 5-alpha-reductase inhibitors should see maximum ef- ficacy at approximately::
- months
- / 2
• Doxycycline (Doryx) is LEAST effective in the treatment of:: Escherichia coli